Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall

FEBS Journal

Volumn 277, Issue 7, 2010, Pages 1713-1725

  Torrent, Marc ^a   Badia, Marina ^a   Moussaoui, Mohammed ^a   Sanchez, Daniel ^a   Nogués, M Victòria ^a   Boix, Ester ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Antimicrobial proteins; Cell wall; ECP; Immunity; RNase 7

Indexed keywords

LIPOPOLYSACCHARIDE; LYSINE; RIBONUCLEASE; RIBONUCLEASE III; RIBONUCLEASE VII; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIGEN ANTIBODY REACTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BINDING AFFINITY; CELL VIABILITY; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MEMBRANE DAMAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CELL WALL; EOSINOPHIL CATIONIC PROTEIN; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEASES; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA;

EID: 77949586101     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07595.x     Document Type: Article

References (43)

1. Ahlstedt S (1995) Clinical application of eosinophilic cationic protein in asthma. Allergy Proc 16, 59 62.
2. Linch SN, Kelly AM, Danielson ET, Pero R, Lee JJ Gold JA (2009) Mouse eosinophils possess potent antibacterial properties in vivo. Infect Immun 77, 4976 4982.
3. Harder J Schroder JM (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277, 46779 46784.
4. Schroder JM Harder J (2006) Antimicrobial skin peptides and proteins. Cell Mol Life Sci 63, 469 486.
5. Koten B, Simanski M, Glaser R, Podschun R, Schroder JM Harder J (2009) RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PLoS ONE 4, e6424.
6. Zhang J, Dyer KD Rosenberg HF (2003) Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res 31, 602 607.
7. Boix E Nogues MV (2007) Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence. Mol Biosyst 3, 317 335.
8. Boix E, Nikolovski Z, Moiseyev GP, Rosenberg HF, Cuchillo CM Nogues MV (1999) Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. J Biol Chem 274, 15605 15614.
9. Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, Chang MD, Chen C, Wu SH Liao YD (2007) The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem 282, 4626 4633.
10. Torrent M, Sanchez D, Buzon V, Nogues MV, Cladera J Boix E (2009) Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7. Biochim Biophys Acta 1788, 1116 1125.
11. Pizzo E D'Alessio G (2007) The success of the RNase scaffold in the advance of biosciences and in evolution. Gene 406, 8 12.
12. Dyer KD Rosenberg HF (2006) The RNase a superfamily: generation of diversity and innate host defense. Mol Divers 10, 585 597.
13. Torrent M, Cuyas E, Carreras E, Navarro S, Lopez O, de la Maza A, Nogues MV, Reshetnyak YK Boix E (2007) Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. Biochemistry 46, 720 733.
14. Torrent M, Navarro S, Moussaoui M, Nogues MV Boix E (2008) Eosinophil cationic protein high affinity binding to bacteria wall lipopolysaccharides and peptidoglycans. Biochemistry 47, 3544 3555.
15. Carreras E, Boix E, Rosenberg HF, Cuchillo CM Nogues MV (2003) Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry 42, 6636 6644.
16. Fan TC, Fang SL, Hwang CS, Hsu CY, Lu XA, Hung SC, Lin SC Chang MD (2008) Characterization of molecular interactions between eosinophil cationic protein and heparin. J Biol Chem 283, 25468 25474.
17. Torrent M, de la Torre BG, Nogues VM, Andreu D Boix E (2009) Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem J 421, 425 434.
18. Torrent M, Nogues MV Boix E (2009) A theoretical approach to spot active regions in antimicrobial proteins. BMC Bioinformatics 10, 373 382.
19. Boix E, Torrent M, Sanchez D Nogues MV (2008) The antipathogen activities of eosinophil cationic protein. Curr Pharm Biotechnol 9, 141 152.
20. Domachowske JB, Dyer KD, Adams AG, Leto TL Rosenberg HF (1998) Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 26, 3358 3363.
21. Rosenberg HF (2008) RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol 83, 1079 1087.
22. Rosenberg HF (1995) Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem 270, 7876 7881.
23. Hancock RE Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24, 1551 1557.
24. Gorr SU, Sotsky JB, Shelar AP Demuth DR (2008) Design of bacteria-agglutinating peptides derived from parotid secretory protein, a member of the bactericidal/permeability increasing-like protein family. Peptides 29, 2118 2127.
25. Irie M, Nitta K Nonaka T (1998) Biochemistry of frog ribonucleases. Cell Mol Life Sci 54, 775 784.
26. Rosenfeld Y Shai Y (2006) Lipopolysaccharide (endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 1758, 1513 1522.
27. Weidenmaier C, Kristian SA Peschel A (2003) Bacterial resistance to antimicrobial host defenses - an emerging target for novel antiinfective strategies? Curr Drug Targets 4, 643 649.
28. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X Ventura S (2007) AGGRESCAN: a server for the prediction and evaluation of 'hot spots' of aggregation in polypeptides. BMC Bioinformatics 8, 65.
29. Cho S, Beintema JJ Zhang J (2005) The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85, 208 220.
30. Cho S Zhang J (2007) Zebrafish ribonucleases are bactericidal: implications for the origin of the vertebrate RNase A superfamily. Mol Biol Evol 24, 1259 1268.
31. Nitto T, Dyer KD, Czapiga M Rosenberg HF (2006) Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus. J Biol Chem 281, 25622 25634.
32. Hileman RE, Fromm JR, Weiler JM Linhardt RJ (1998) Glycosaminoglycan- protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20, 156 167.
33. Gandhi NS Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72, 455 482.
34. Sur S, Glitz DG, Kita H, Kujawa SM, Peterson EA, Weiler DA, Kephart GM, Wagner JM, George TJ, Gleich GJ et al. (1998) Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes. J Leukoc Biol 63, 715 722.
35. Bystrom J, Garcia RC, Hakansson L, Karawajczyk M, Moberg L, Soukka J Venge P (2002) Eosinophil cationic protein is stored in, but not produced by, peripheral blood neutrophils. Clin Exp Allergy 32, 1082 1091.
36. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L Trulson A (1999) Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 29, 1172 1186.
37. Schroder JM Harder J (2006) Innate antimicrobial peptides in the skin. Med Sci (Paris) 22, 153 157.
38. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171, 3262 3269.
39. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347, 1151 1160.
40. Ong PY Leung DY (2002) Atopic dermatitis. Clin Allergy Immunol 16, 355 379.
41. Kawabata SI Iwanaga S (1997) Big defensin and tachylectins -1 and -2. In Methods in Molecular Biology: Antibacterial Peptide Protocols (Shafer WM ed 51 61. Humana Press Inc, Totowa, NJ.
42. Roth BL, Poot M, Yue ST Millard PJ (1997) Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl Environ Microbiol 63, 2421 2431.
43. Mallorquí-Fernández G, Pous J, Peracaula R, Aymamí J, Maeda T, Tada H, Yamada H, Seno M, de Llorens R, Gomis-Rüth FX et al. (2000) Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. J Mol Biol 300, 1297 1307.